文献速递神经肿瘤

纳米颗粒封装实现IGF-Trap全身递送抑制脑内胶质瘤生长

Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth.
PubMed 文献 · Neuro Oncol · 2025-01-01

本研究评估新型IGF轴抑制剂IGF-Trap对胶质瘤细胞的敏感性并优化其脑内递送。结果显示,全身或直接脑内给予IGF-Trap均可抑制皮下或原位植入的胶质瘤生长并延长生存;将IGF-Trap封装于三甲基壳聚糖(TRIOZAN™)纳米颗粒后静脉注射,可增加脑内摄取和滞留,并改善对脑内生长肿瘤的疗效。

要点

  • 全身或直接脑内给予IGF-Trap均可抑制胶质瘤生长并延长生存。
  • 三甲基壳聚糖纳米颗粒封装增加IGF-Trap脑内摄取和滞留。
  • 纳米颗粒封装IGF-Trap改善对脑内生长肿瘤的疗效。

核心结论

  • IGF-Trap是脑内胶质瘤生长的有效抑制剂,纳米颗粒封装可改善生物制剂向脑内递送并增强治疗反应。

研究设计与样本

  • 研究评估IGF-Trap对人胶质瘤干细胞MES-1123和U87 MG细胞及小鼠GL261细胞在体内皮下和原位植入后的生长影响。

主要发现

  • 皮下或原位脑内植入的胶质瘤细胞生长分别被全身和直接脑内给予IGF-Trap抑制,并导致生存延长。
  • 静脉注射前将IGF-Trap封装于三甲基壳聚糖(TRIOZAN™)纳米颗粒,发现封装增加IGF-Trap在脑内的摄取和滞留,并改善对脑内生长肿瘤的疗效。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma is an aggressive brain cancer with a 5-year survival rate of 5-10%. Current therapeutic options are limited, due in part to drug exclusion by the blood-brain barrier, restricting access of targeted drugs to the tumor. The receptor for the type 1 insulin-like growth factor (IGF-1R) was identified as a therapeutic target in glioblastoma. We previously reported that the intracerebral growth of glioma cells with reduced IGF-1R levels was inhibited. The objectives of this study were to evaluate the sensitivity of glioma cells to a novel IGF-axis inhibitor, the IGF-Trap, and optimize its delivery to the brain. METHODS: We tested the effect of the IGF-Trap on the growth of the human glioma stem cells MES-1123 and U87 MG cells, and of murine GL261 cells in vivo, using subcutaneous and orthotopic implantation. RESULTS: We show that the growth of glioma cells implanted subcutaneously or orthotopically in the brain was inhibited by systemic and direct intracerebral administration of IGF-Trap, respectively, resulting in increased survival. To increase the efficiency of systemic delivery to the brain, we encapsulated the IGF-Trap in trimethyl chitosan (TRIOZAN™) nanoparticles prior to intravenous injection. We found that nanoparticle encapsulation increased the uptake and retention of the IGF-Trap in the brain and resulted in an improved therapeutic effect against intra-cerebrally growing tumors. CONCLUSION: Our results identify the IGF-Trap as a potent inhibitor of intracerebral glioma growth and show that encapsulation in nanoparticles can improve delivery of biologics such as the IGF-Trap to the brain, thereby enhancing the therapeutic response.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Chen YM, Chambon J, Moquin A, et al. Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth. Neuro Oncol. 2025. PMID: 39879581. doi:10.1093/neuonc/noaf011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。